Financhill
Buy
51

CTEV Quote, Financials, Valuation and Earnings

Last price:
$40.30
Seasonality move :
-17.39%
Day range:
$37.36 - $40.00
52-week range:
$4.80 - $40.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.69x
P/B ratio:
44.16x
Volume:
63K
Avg. volume:
91.8K
1-year change:
128.86%
Market cap:
$654.7M
Revenue:
$930.6M
EPS (TTM):
-$72.72

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CTEV
Claritev
$222.7M -$2.20 -1.76% -93.41% $34.50
DRIO
DarioHealth
$7.5M -$0.06 10.39% -29.16% $2.38
FOXO
FOXO Technologies
-- -- -- -- --
OTRK
Ontrak
$3.4M -- -13% -- $4.00
SPOK
Spok Holdings
$34M $0.24 3% 18.18% $20.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CTEV
Claritev
$39.83 $34.50 $654.7M -- $0.00 0% 0.69x
DRIO
DarioHealth
$0.70 $2.38 $30.6M -- $0.00 0% 1.03x
FOXO
FOXO Technologies
$0.21 -- $1.4M -- $0.00 0% 0.06x
OTRK
Ontrak
$1.42 $4.00 $6M -- $0.00 0% 0.70x
SPOK
Spok Holdings
$16.47 $20.00 $338.8M 21.12x $0.31 7.59% 2.44x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CTEV
Claritev
99.68% -1.341 1360.84% 0.77x
DRIO
DarioHealth
28.37% -0.791 111.66% 1.76x
FOXO
FOXO Technologies
38.2% 11.399 144.44% 0.09x
OTRK
Ontrak
67.21% -0.005 155.76% 0.50x
SPOK
Spok Holdings
-- 0.936 -- 0.99x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CTEV
Claritev
$170.9M $9.7M -23.75% -283.02% 0.76% -$68.9M
DRIO
DarioHealth
$3.9M -$9.4M -45.31% -63.94% -139.35% -$6.7M
FOXO
FOXO Technologies
$1.3M -$1.5M -214.25% -- 8.49% -$1.3M
OTRK
Ontrak
$746K -$5.9M -144.37% -222.91% -290.04% -$2.8M
SPOK
Spok Holdings
$29.1M $6.1M 10.19% 10.19% 16.74% $1.5M

Claritev vs. Competitors

  • Which has Higher Returns CTEV or DRIO?

    DarioHealth has a net margin of -30.83% compared to Claritev's net margin of -136.66%. Claritev's return on equity of -283.02% beat DarioHealth's return on equity of -63.94%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    DRIO
    DarioHealth
    57.49% -$0.14 $102.9M
  • What do Analysts Say About CTEV or DRIO?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -13.38%. On the other hand DarioHealth has an analysts' consensus of $2.38 which suggests that it could grow by 241.04%. Given that DarioHealth has higher upside potential than Claritev, analysts believe DarioHealth is more attractive than Claritev.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    DRIO
    DarioHealth
    3 1 0
  • Is CTEV or DRIO More Risky?

    Claritev has a beta of 0.515, which suggesting that the stock is 48.504% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.583, suggesting its more volatile than the S&P 500 by 58.337%.

  • Which is a Better Dividend Stock CTEV or DRIO?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or DRIO?

    Claritev quarterly revenues are $231.3M, which are larger than DarioHealth quarterly revenues of $6.8M. Claritev's net income of -$71.3M is lower than DarioHealth's net income of -$9.2M. Notably, Claritev's price-to-earnings ratio is -- while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.69x versus 1.03x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.69x -- $231.3M -$71.3M
    DRIO
    DarioHealth
    1.03x -- $6.8M -$9.2M
  • Which has Higher Returns CTEV or FOXO?

    FOXO Technologies has a net margin of -30.83% compared to Claritev's net margin of -19.45%. Claritev's return on equity of -283.02% beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    FOXO
    FOXO Technologies
    39.94% -$0.37 $15.7M
  • What do Analysts Say About CTEV or FOXO?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -13.38%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Claritev has higher upside potential than FOXO Technologies, analysts believe Claritev is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is CTEV or FOXO More Risky?

    Claritev has a beta of 0.515, which suggesting that the stock is 48.504% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CTEV or FOXO?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or FOXO?

    Claritev quarterly revenues are $231.3M, which are larger than FOXO Technologies quarterly revenues of $3.2M. Claritev's net income of -$71.3M is lower than FOXO Technologies's net income of -$616.5K. Notably, Claritev's price-to-earnings ratio is -- while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.69x versus 0.06x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.69x -- $231.3M -$71.3M
    FOXO
    FOXO Technologies
    0.06x -- $3.2M -$616.5K
  • Which has Higher Returns CTEV or OTRK?

    Ontrak has a net margin of -30.83% compared to Claritev's net margin of -341.65%. Claritev's return on equity of -283.02% beat Ontrak's return on equity of -222.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    OTRK
    Ontrak
    36.99% -$1.65 $14.2M
  • What do Analysts Say About CTEV or OTRK?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -13.38%. On the other hand Ontrak has an analysts' consensus of $4.00 which suggests that it could grow by 181.69%. Given that Ontrak has higher upside potential than Claritev, analysts believe Ontrak is more attractive than Claritev.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    OTRK
    Ontrak
    0 0 0
  • Is CTEV or OTRK More Risky?

    Claritev has a beta of 0.515, which suggesting that the stock is 48.504% less volatile than S&P 500. In comparison Ontrak has a beta of 2.377, suggesting its more volatile than the S&P 500 by 137.727%.

  • Which is a Better Dividend Stock CTEV or OTRK?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or OTRK?

    Claritev quarterly revenues are $231.3M, which are larger than Ontrak quarterly revenues of $2M. Claritev's net income of -$71.3M is lower than Ontrak's net income of -$6.9M. Notably, Claritev's price-to-earnings ratio is -- while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.69x versus 0.70x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.69x -- $231.3M -$71.3M
    OTRK
    Ontrak
    0.70x -- $2M -$6.9M
  • Which has Higher Returns CTEV or SPOK?

    Spok Holdings has a net margin of -30.83% compared to Claritev's net margin of 14.32%. Claritev's return on equity of -283.02% beat Spok Holdings's return on equity of 10.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    SPOK
    Spok Holdings
    80.13% $0.25 $151.7M
  • What do Analysts Say About CTEV or SPOK?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -13.38%. On the other hand Spok Holdings has an analysts' consensus of $20.00 which suggests that it could grow by 21.43%. Given that Spok Holdings has higher upside potential than Claritev, analysts believe Spok Holdings is more attractive than Claritev.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    SPOK
    Spok Holdings
    1 0 0
  • Is CTEV or SPOK More Risky?

    Claritev has a beta of 0.515, which suggesting that the stock is 48.504% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.563, suggesting its less volatile than the S&P 500 by 43.737%.

  • Which is a Better Dividend Stock CTEV or SPOK?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.59% to investors and pays a quarterly dividend of $0.31 per share. Claritev pays -- of its earnings as a dividend. Spok Holdings pays out 176.29% of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or SPOK?

    Claritev quarterly revenues are $231.3M, which are larger than Spok Holdings quarterly revenues of $36.3M. Claritev's net income of -$71.3M is lower than Spok Holdings's net income of $5.2M. Notably, Claritev's price-to-earnings ratio is -- while Spok Holdings's PE ratio is 21.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.69x versus 2.44x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.69x -- $231.3M -$71.3M
    SPOK
    Spok Holdings
    2.44x 21.12x $36.3M $5.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Reddit Stock Be In 5 Years?
Where Will Reddit Stock Be In 5 Years?

On a wet March morning last year, the famously orange…

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Is Target’s Dividend Worth Buying?
Is Target’s Dividend Worth Buying?

Retail giant Target (NYSE:TGT) has been through an extremely volatile…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
37
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
49
RGC alert for Jun 17

Regencell Bioscience Holdings [RGC] is up 30.47% over the past day.

Buy
75
ARQQ alert for Jun 17

Arqit Quantum [ARQQ] is up 6.36% over the past day.

Buy
59
SYM alert for Jun 17

Symbotic [SYM] is down 3.91% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock